New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Learning to Recognize the Symptoms of Pancreatic Cancer
Laura Metzger had many different symptoms of pancreatitis and pancreatic cancer but no one put the picture together for years.
Using Molecular Tumor Profiling to Determine the Best Pancreatic Cancer Treatment
A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.
Choosing the Right Doctor
Rita Krueger made an important decision that changed her pancreatic cancer treatment when she got a second opinion.
Following a Treatment Plan
As a retired oncology nurse, Virginia Wetcher knew she needed a good treatment plan after her pancreatic cancer diagnosis.
The Butterfly Effect and Living Every Day to My Fullest
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
Testing a Combination for Metastatic Pancreatic Cancer
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
Going Two Rounds Against Pancreatic Cancer
Anthony DelRusso has battled pancreatic cancer twice, first with chemo and a Whipple, and again with a total pancreatectomy and radiation.
You Only Have One Life to Live
Tom Stachler traveled from his home in Michigan to an expert surgeon in Wisconsin to have Whipple surgery for his pancreatic cancer.
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.